Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
06/1994
06/07/1994US5319072 Human antithrombin-III preparation
06/07/1994US5318899 Platelet aggregation inhibitors
06/07/1994US5318679 Photoprotected amines attached to support surface are selectively irradiated to deprotect preselected area so that support surface are subjected to chemical reaction to link aminoacids to the selectively deprotected area
06/07/1994CA1330145C Protein label and drug delivery system
06/07/1994CA1330050C Enrichment and concentration of proteins by ultrafiltration
06/01/1994EP0599444A1 Dual action inhibitors
06/01/1994EP0599344A1 Process for the stabilization of proteins
06/01/1994EP0599142A2 Method for making immuno-conjugates
06/01/1994EP0598899A1 Liquid phase synthesis of peptides and peptide derivatives
06/01/1994EP0555418A4 Peptide binding assays with mhc antigens
06/01/1994EP0483143B1 Membrane affinity apparatus and purification methods related thereto
05/1994
05/31/1994US5317092 Protein purification method
05/31/1994US5317089 Monoclonal antibodies against IFN-omega, processes for preparing them and their use in the purification and detection of IFN-omega
05/31/1994US5317084 Process for large-scale production of antimicrobal peptide in high purity
05/31/1994US5317014 Peptides and pseudopeptides derived from tachykinin
05/31/1994US5317011 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses
05/31/1994US5317009 Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof
05/31/1994US5316954 Chemical reactors with multicompartment tubes and means for detaching, coupling and joining
05/31/1994US5316947 Synthetic isohirudins with improved stability
05/26/1994WO1994011738A1 Determination of peptide motifs on mhc molecules
05/26/1994WO1994011399A1 Specifically crosslinked hemoglobin with free functionality
05/26/1994WO1994011391A1 Compounds useful as sweetening agents and process for their preparation
05/26/1994WO1994011388A1 Support for the synthesis of modular polymers
05/26/1994WO1994011012A1 Substituted dipeptide analogs promote release of growth hormone
05/26/1994CA2149132A1 Specifically crosslinked hemoglobin with free functionality
05/26/1994CA2148591A1 Support for the synthesis of modular polymers
05/26/1994CA2147503A1 Substituted dipeptide analogs promote release of growth hormone
05/25/1994EP0598034A1 Production of peptide amides
05/25/1994EP0597997A1 Lanthionine bridged peptides
05/25/1994EP0597847A1 Synthetic senescent cell antigen
05/25/1994EP0597845A1 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2
05/25/1994EP0597829A1 Novel monoclonal antibody to novel antigen associated with human tumors
05/25/1994CA2109636A1 Process for preparing immunoconjugates
05/24/1994US5314991 Recombinant 40 KDa Dermatophagoides farinae allergen
05/24/1994US5314872 Glucan sulfate, stabilized fibroblast growth factor composition
05/24/1994US5314829 Method for imaging informational biological molecules on a semiconductor substrate
05/24/1994US5314593 Capillary tube with reversible protein interaction and method
05/24/1994CA1329862C Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors
05/24/1994CA1329763C Stabilized fgf composition and production thereof
05/19/1994DE4238416A1 Bestimmung von Peptidmotiven auf MHC-Molekülen Determination of peptide motifs on MHC molecules
05/18/1994EP0597699A2 Protein secreted by cancer cells
05/18/1994EP0597400A1 Dibenzosuberyl and dibenzosuberenyl derivatives and their use as linker groups
05/18/1994EP0597043A1 Porcine adipocyte antigens and their use in the immunological control of fat
05/18/1994EP0516749B1 Immobilized polyethylene oxide star molecules for bioapplications
05/18/1994EP0463043B1 Method for stabilizing the hybridization of complementary polynucleotide sequences
05/18/1994EP0335899B1 Immunoaffinity purification system
05/18/1994CN1086825A The present invention is concerned with tri- and tetracyclic compounds
05/18/1994CN1086824A Calcium channel blocking polypeptide from agelenopsis aperta
05/17/1994US5312809 Physiologically active substance derived from malt and process for the production thereof
05/17/1994US5312808 Polyoxyethylene glycol conjugates with hemoglobin
05/17/1994US5312736 DNA-sequence encoding the analog; expression vector containing the sequence; transformed or transfected microorganism or cell line comprising the vector; culture preparation of analog; drug including analog
05/17/1994CA1329681C N_-(1-carboxy-3-phenylpropyl)-l-lysine derivative and process of producing lysinopril using the compound
05/11/1994WO1994010206A1 Intrinsic inhibitors of aldose reductase
05/11/1994WO1994010203A2 Op-3-induced morphogenesis
05/11/1994WO1994010196A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma
05/11/1994WO1994010195A1 Calcium channel blocking polypeptides from heteropoda venatoria
05/11/1994WO1994010192A1 Process for manufacturing crystals of growth hormone and crystals thereby obtained
05/11/1994WO1994010191A1 Low allergenic proteins
05/11/1994WO1994009824A1 Allergenic extracts
05/11/1994EP0596479A2 Basophil-binding monoclonal antibody, method for separation of basophils, method for chemical mediator release from basophils, and method for testing release of basophil-derived chemical mediators
05/11/1994EP0596459A2 Process for purifying recombinant proteins, and use of products thereof
05/11/1994EP0596350A1 Cyclopeptides
05/11/1994EP0596321A2 Process of unidimensional separation and identification of glycanes, the use of this process for the construction of databanks, the structure characterization of glycans and the relative determination of the Stokes radius of glycanes
05/11/1994EP0596024A1 Lipid conjugates of therapeutic peptides and protease inhibitors
05/11/1994EP0595997A1 PROTEIN V: A NOVEL IgG BINDING FACTOR
05/11/1994EP0595993A1 Isolation of charged particles from fluids
05/11/1994EP0595878A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use
05/11/1994EP0595822A1 Thyroidal receptor for n-acetylglucosamine
05/11/1994EP0595798A1 Bispecific heteroantibodies with dual effector functions
05/11/1994EP0558671A4 Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
05/11/1994EP0516672B1 Process and device for the simultaneous synthesis of several polypeptides
05/11/1994EP0344177B1 Porous wafer for segmented synthesis of biopolymers
05/11/1994CA2148504A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma
05/11/1994CA2148007A1 Allergenic extracts
05/11/1994CA2147741A1 Low allergenic proteins
05/11/1994CA2147598A1 Op-3-induced morphogenesis
05/11/1994CA2147494A1 Intrinsic inhibitors of aldose reductase
05/10/1994US5310894 Ease of purification
05/10/1994US5310883 Stabilized versions of glu-3,5-basic FGF having eliminated disulfide scrambled forms; wound healing agents; promoters of angiogenesis, neutrotropism and chemotaxis
05/10/1994US5310882 Somatotropins with alterations in the α-helix 3 region
05/10/1994US5310881 Reaction product of mucopolysaccharides and enzymes, sustained release, drugs
05/10/1994US5310873 Cyclohexapeptide compound
05/10/1994US5310740 Renin inhibitors
05/10/1994US5310737 Benzo-fused lactams that promote the release of growth hormone
05/10/1994US5310726 Antifungal, antiparasite, echinicandin B derivative
05/10/1994US5310688 Method and apparatus for eluting proteins in affinity membrane process
05/10/1994US5310663 Affinity peptides
05/10/1994US5310648 Polymer-metal chelate compound
05/10/1994US5310462 Quantitation of samples utilizing capillary electrophoresis
05/10/1994CA1329446C Peptides with laminin activity
05/10/1994CA1329445C Process for preparing n-¬1(s)-ethoxycarbonyl-3- phenylpropyl|-l-alanyl-l-proline
05/10/1994CA1329444C Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same
05/10/1994CA1329373C Process for recovering refractile bodies containing heterologous proteins from microbial hosts
05/07/1994CA2102547A1 Process for preparing conjugates consisting of a specific binding partner and a carbohydrate-containing protein
05/05/1994DE4335366A1 Verfahren zur Herstellung eines kristallinen Typ A Botulinum Toxins als therapeutische Arznei A process for preparing a crystalline botulinum toxin type A as a therapeutic drug
05/04/1994EP0595743A1 Bihaptinic derivatives for binding for technetium or rhenium, process for their preparation, application for diagnosis and therapy, kits and immunological reactants comprising them
05/04/1994EP0594764A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor
05/04/1994EP0514413B1 Immunologically active peptides or polypeptides from the parvovirus b19
05/04/1994EP0428700B1 Irreversible bombesin antagonists
05/04/1994CA2102251A1 Method for the one-dimensional fractionation and identification of glycans, and the use of this method for setting up data bases and for the determination of the structure of glycans and for the relative determination of the stokes radii glycans